Release Date: 06/09/16 14:46 Summary: Director Resignation, Appendix 3Z-EVM.AX Price Sensitive: No Download Document 476.61KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%